These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11030493)

  • 61. Sodium valproate and haemostasis--what to do.
    Drug Ther Bull; 1984 Mar; 22(6):23-4. PubMed ID: 6425029
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A Woman Experienced Severe Thrombocytopenia When Treated With Fluvastatin].
    Potier A; Dony A; Crapsky A; Ferry O; Piney D; Dufay E
    Therapie; 2015; 70(6):541-4. PubMed ID: 26238127
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy of divalproex for partial epilepsies.
    Smith MC
    Psychopharmacol Bull; 2003; 37 Suppl 2():54-66. PubMed ID: 15021861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
    Puryear LJ; Kunik ME; Workman R
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Generalized edema with risperidone: divalproex sodium treatment.
    Baldassano CF; Ghaemi SN
    J Clin Psychiatry; 1996 Sep; 57(9):422. PubMed ID: 9746451
    [No Abstract]   [Full Text] [Related]  

  • 68. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder.
    Fawcett RG
    J Clin Psychiatry; 1997 Mar; 58(3):125. PubMed ID: 9108818
    [No Abstract]   [Full Text] [Related]  

  • 69. Absorption characteristics of a new valproate formulation: divalproex sodium-coated particles in capsules (Depakote Sprinkle).
    Carrigan PJ; Brinker DR; Cavanaugh JH; Lamm JE; Cloyd JC
    J Clin Pharmacol; 1990 Aug; 30(8):743-7. PubMed ID: 2119396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia.
    Stapnes C; Ryningen A; Gjertsen BT; Bruserud Ø
    Acta Oncol; 2006; 45(3):346-9. PubMed ID: 16644583
    [No Abstract]   [Full Text] [Related]  

  • 71. Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities?
    Hellings JA; Barth FX; Logan M; Cook-Wiens G; Osorio I; Reed RC
    J Clin Psychopharmacol; 2009 Oct; 29(5):492-5. PubMed ID: 19745651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic lupus erythematosus associated with use of valproate.
    Asconapé JJ; Manning KR; Lancman ME
    Epilepsia; 1994; 35(1):162-3. PubMed ID: 8112240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
    Muzyk AJ; Candeloro CL; Christopher EJ
    Gen Hosp Psychiatry; 2010; 32(5):560.e1-3. PubMed ID: 20851283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 76. [A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].
    Ohyama M; Matsumura M; Katsuta K; Nobori T; Matsuyama H; Fukami K; Kiyota R; Yano H; Shima T; Ogawa K
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1211-6. PubMed ID: 2112372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 78. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Valproic acid therapy in childhood epilepsy.
    Coulter DL; Wu H; Allen RJ
    JAMA; 1980 Aug 22-29; 244(8):785-8. PubMed ID: 6771426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.